NSC |
Compound |
Enrichment |
Correlation |
NSC 706744 |
Indenoisoquinoline derivative |
0.0420893367628879 |
0.05518247 |
NSC 708854 |
Null |
0.0420893367628879 |
0.19699813 |
NSC 718191 |
Null |
0.0420893367628879 |
0.050685088 |
NSC 722308 |
N4-octadeyl-arabinocytidylyl-(5'.fwdarw.5')-5-fluoro-2'-deoxy uridine |
0.0420893367628879 |
0.20771463 |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.0420893367628879 |
0.098818503 |
NSC 728319 |
6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride |
0.0420893367628879 |
0.27517823 |
NSC 728512 |
1-Allyl-2-[4-chloro-5-(4-chlorophenylcarbamoyl)-2-methylthio benzenesulfonyl]-3-(5-nitro-2-furfulienimino)guanidine |
0.0420893367628879 |
0.25796354 |
NSC 731155 |
6-(3-Aminopropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno[ 1,2-c]isoquinoline Hydrochloride salt |
0.0420893367628879 |
0.31532872 |
NSC 254681 |
5(8H)-Naphthacenone, 8-acetyl-10-[(3-amino-2,3,6-trideoxy- .alpha.-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,~ 11-trihydroxy-12-imino-1-methoxy-, monohydrochloride, (8S-cis)- (9CI) |
0.0430277102950697 |
0.21852018 |
NSC 58239 |
A 80021F34 |
0.0430277102950697 |
0.30331625 |